NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Numerion Labs

Numerion Labs

Private
San Francisco, CaliforniaAI, Data & Cloud Infrastructurehttps://numerionlabs.ai/

Last Round

Early Stage

VC

Mar 19, 2026

Est. Valuation

$1.71M

Total Funding Raised

$221.42M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Numerion Labs is a biotechnology company that develops an artificial intelligence-driven platform for small molecule drug discovery.

Sector

AI, Data & Cloud Infrastructure

Verticals

ML Platforms, Business Intelligence, Data Integration, Workflow Automation

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Foundation

Keywords

drug discoveryfoundation modelfrontier ai labgenerative chemistrysmall-molecule drugai drug discoverycomputational chemistrypredictive modelingdata engineeringbiotech aimachine learningpharma techai researchgpu infrastructure

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Numerion Labs Comparables

Compare Numerion Labs with similar companies based on industry and business-model similarity.

Numerion Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Valo
45%
RefinedScience
44%
PostEra
42%

Numerion Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early Stage VCMar 19, 2026
Series CMar 1, 2024
GrantOct 6, 2020
Series BAug 11, 2020
Series AMar 7, 2018
Seed
Jun 3, 2015

Numerion Labs Investors

Notable investors and investment history

Numerion Labs investors
InvestorRounds
Sanabil InvestmentsSeries B
Baidu VenturesSeries A
Threshold VenturesSeed
Dolby Family VenturesSeries A, Series B
B Capital GroupSeries C, Series A, Series B
Khosla VenturesSeries A, Seed, Series C
BV Investment PartnersSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 19, 2026

    $20M raised in early stage VC round.

  • Mar 7, 2018

    $45M round led by Leaps by Bayer, DCVC, and B Capital Group.

Numerion Labs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Numerion Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Numerion Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Year Founded2012
Last FundingMar 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.